Articles by M. Boldrin (2)

Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study

R. Ratner, M. Nauck, C. Kapitza, V. Asnaghi, M. Boldrin and R. Balena

Diabetic Medicine 27 ( 5 ): 556 - 562 , 2010

Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial

M. Nauck, E. Horton, M. Andjelkovic, F. J. Ampudia-Blasco, C. T. Parusel, M. Boldrin and R. Balena

Diabetic Medicine 30 ( 1 ): 109 - 113 , 2013

Do you have a suggestion for journals

Suggest Journal